Last Updated: May 3, 2026

Litigation Details for Atchison v. Hubbell Industrial Controls, Inc. (M.D. Tenn. 2024)


✉ Email this page to a colleague

« Back to Dashboard


Atchison v. Hubbell Industrial Controls, Inc. (M.D. Tenn. 2024)

Docket 3:24-cv-00922 Date Filed 2024-07-29
Court District Court, M.D. Tennessee Date Terminated
Cause 28:1332 Diversity-Breach of Fiduciary Duty Assigned To Aleta Arthur Trauger
Jury Demand Both Referred To Jeffery S. Frensley
Patents 10,029,010; 10,155,002; 11,040,004; 11,097,006; 8,106,022; 9,127,013
Link to Docket External link to docket
Small Molecule Drugs cited in Atchison v. Hubbell Industrial Controls, Inc.
The small molecule drugs covered by the patents cited in this case are ⤷  Start Trial , ⤷  Start Trial , ⤷  Start Trial , ⤷  Start Trial , ⤷  Start Trial , ⤷  Start Trial , ⤷  Start Trial , ⤷  Start Trial , and ⤷  Start Trial .

Litigation summary and analysis for: Atchison v. Hubbell Industrial Controls, Inc. (M.D. Tenn. 2024)

Last updated: April 28, 2026

What is the litigation status and patent exposure in Atchison v. Hubbell Industrial Controls, Inc., No. 3:24-cv-00922?

What case is this and where does it sit procedurally?

Atchison v. Hubbell Industrial Controls, Inc. is filed in the U.S. District Court for the Middle District of Tennessee as case number 3:24-cv-00922. The case caption indicates a civil action against Hubbell Industrial Controls, Inc. The filing date is within 2024 (as reflected by the docket number format “3:24-cv-00922”).

The provided request does not include docket events, complaint text, asserted patent numbers, claims, infringement allegations, technology descriptions, claim constructions, motion practice, or any court orders. Without those items, a litigation merits summary, claim-by-claim exposure analysis, or validity/infringement posture cannot be produced accurately.

What are the core claims and asserted patents?

No asserted patents, claim numbers, or infringement theories are included in the information provided. A litigation analysis at the level expected for R&D or investment decisions requires at minimum: asserted patent identifiers, claim sets, alleged products accused (models/part numbers), and the alleged infringement acts (manufacture, use, sale, import; specific jurisdictions; time windows).

What motions and rulings define the current posture?

No docket milestones or rulings are provided (no dismissal orders, transfer orders, Markman schedule, claim construction orders, summary judgment rulings, stay orders, or venue/personal jurisdiction determinations).

A correct posture assessment depends on:

  • whether the court has issued a Markman ruling or a claim construction schedule
  • whether any dispositive motions are pending or decided
  • whether discovery has started or been stayed
  • whether the plaintiff withdrew, amended, or narrowed asserted claims

What is the likely damages and injunction risk profile?

No information is provided on the remedies sought (damages only versus injunctive relief), the asserted patent type (utility versus design), the plaintiff’s licensing history, or the accused product footprint. Without the complaint or any order specifying remedies, any damages and injunction analysis would be speculative.

What does the case imply for freedom-to-operate and product roadmap risk?

No asserted claims or accused products are given. A freedom-to-operate view depends on matching:

  • claim limitations to product architectures
  • design-around options (if known)
  • prosecution history scope if provided
  • non-infringement and invalidity arguments available for the technology area at issue

What information would normally be extracted for a litigation intelligence package?

For a complete, business-usable litigation summary of a patent case, the extracted facts typically include:

Pleading and technical scope

  • asserted patent numbers and filing/priority dates
  • asserted claims and claim terms
  • accused product identifiers
  • infringement allegations mapped by claim

Defenses and validity

  • invalidity grounds (112, 101, 102, 103, double patenting)
  • prosecution history estoppel or disclaimer content (if relevant)
  • inequitable conduct assertions (if any)

Litigation posture

  • scheduling order dates
  • Markman hearing date and claim construction ruling dates
  • summary judgment and Daubert motion status
  • discovery scope and any protective orders

Remedies and leverage

  • damages theories (lost profits, reasonable royalty, design-around cost impacts)
  • request for permanent injunction
  • ongoing royalties proposal (if any)

None of the above is present in the current input.

Litigation summary table

Item Status from provided input
Court / case number Known: M.D. Tenn., 3:24-cv-00922
Parties Known: Atchison v. Hubbell Industrial Controls, Inc.
Asserted patents Not provided
Asserted claims Not provided
Accused products / models Not provided
Infringement theory detail Not provided
Validity grounds Not provided
Motions and rulings Not provided
Discovery / Markman status Not provided
Remedies sought Not provided
Current procedural posture Not determinable from provided input

Actionable business conclusions

No actionable conclusions on claim scope, likely outcomes, settlement leverage, or R&D risk can be stated from the information supplied.

Key Takeaways

  • The only concrete information provided is the case caption and docket number: Atchison v. Hubbell Industrial Controls, Inc., 3:24-cv-00922 (M.D. Tenn.).
  • The input contains no asserted patents, claims, accused products, defenses, motions, or orders, so a litigation merits summary and exposure analysis cannot be completed accurately.

FAQs

  1. What court is this case in?
    The case is in the U.S. District Court for the Middle District of Tennessee under case number 3:24-cv-00922.

  2. Who are the parties?
    The plaintiff is Atchison and the defendant is Hubbell Industrial Controls, Inc.

  3. What patents are asserted?
    Asserted patents are not included in the provided information.

  4. Has the court issued a Markman or claim construction order?
    Markman status and any claim construction orders are not included in the provided information.

  5. What is the current litigation posture?
    Motions and order history are not included in the provided information, so current posture cannot be stated.

References

[1] Public docket information is not included in the provided input, so no external sources can be cited.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.